Weinberg AD - Search Results

1

OX40-enhanced tumor rejection and effector T cell differentiation decreases with age.

Ruby CE, Weinberg AD. Ruby CE, et al. Among authors: weinberg ad. J Immunol. 2009 Feb 1;182(3):1481-9. doi: 10.4049/jimmunol.182.3.1481. J Immunol. 2009. PMID: 19155495 Free PMC article.

2

Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis.

Weinberg AD, Whitham R, Swain SL, Morrison WJ, Wyrick G, Hoy C, Vandenbark AA, Offner H. Weinberg AD, et al. J Immunol. 1992 Apr 1;148(7):2109-17. J Immunol. 1992. PMID: 1347550

3

Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.

Chou YK, Morrison WJ, Weinberg AD, Dedrick R, Whitham R, Bourdette DN, Hashim G, Offner H, Vandenbark AA. Chou YK, et al. Among authors: weinberg ad. J Immunol. 1994 Mar 1;152(5):2520-9. J Immunol. 1994. PMID: 7510747

4

Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis.

Weinberg AD, Wallin JJ, Jones RE, Sullivan TJ, Bourdette DN, Vandenbark AA, Offner H. Weinberg AD, et al. J Immunol. 1994 May 1;152(9):4712-21. J Immunol. 1994. PMID: 7512604

5

Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis.

Offner H, Vainiene M, Celnik B, Weinberg AD, Buenafe A, Vandenbark AA. Offner H, et al. Among authors: weinberg ad. J Immunol. 1994 Dec 1;153(11):4988-96. J Immunol. 1994. PMID: 7525721

6

OX-40: life beyond the effector T cell stage.

Weinberg AD, Vella AT, Croft M. Weinberg AD, et al. Semin Immunol. 1998 Dec;10(6):471-80. doi: 10.1006/smim.1998.0146. Semin Immunol. 1998. PMID: 9826580 Review.

7

Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

Weinberg AD, Wegmann KW, Funatake C, Whitham RH. Weinberg AD, et al. J Immunol. 1999 Feb 1;162(3):1818-26. J Immunol. 1999. PMID: 9973447

8

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.

Maxwell JR, Weinberg A, Prell RA, Vella AT. Maxwell JR, et al. J Immunol. 2000 Jan 1;164(1):107-12. doi: 10.4049/jimmunol.164.1.107. J Immunol. 2000. PMID: 10605000

9

Engagement of the OX-40 receptor in vivo enhances antitumor immunity.

Weinberg AD, Rivera MM, Prell R, Morris A, Ramstad T, Vetto JT, Urba WJ, Alvord G, Bunce C, Shields J. Weinberg AD, et al. J Immunol. 2000 Feb 15;164(4):2160-9. doi: 10.4049/jimmunol.164.4.2160. J Immunol. 2000. PMID: 10657670

10

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, Croft M. Gramaglia I, et al. Among authors: weinberg ad. J Immunol. 2000 Sep 15;165(6):3043-50. doi: 10.4049/jimmunol.165.6.3043. J Immunol. 2000. PMID: 10975814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters